Meningitis associated with Vancomycin resistant Enterococcus casseliflavus: First report

Abstract

Enterococci are present in the gastrointestinal system as normal floral components. In the past two decades members of the genus Enterococcus have emerged as important nosocomial pathogens worldwide. Enterococci may cause a range of different disorders such as urinary tract, intraabdominal, and wound infections, as well as endocarditis, meningitis and bacteraemia. Nosocomial enterococcal meningitis is most commonly observed following ventriculoperitoneal shunt operations. Vancomycin resistant enterococcus (VRE) represents 30% of all enterococci infections. This report presents a vancomycin-resistant Enterococcus casseliflavus meningitis case in a 66-year-old patient with ventriculoperitoneal shunt, which has not been reported in the literature before. Successful outcomes were obtained with daptomycin plus linezolid combined treatment in VRE meningitis. Treatment recommendations in VRE meningitis are also discussed in this article.

Keywords

• Vancomycin-resistant enterococcus, Enterococcus casseliflavus

Meningitis associated with Vancomycin resistant Enterococcus casseliflavus: First report

Öz

Anahtar Kelimeler

• -

References

1. Arias CA, Murray BE. Enterococcus species, Streptococcus bovis and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseas- es. Seventh edition. New York. Churchill Livingstone 2010; 2643-2653.
2. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin resistance enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Disease 2007;58:163-170.
3. Stevenson KB, Murray EW, Sarubbi FA. Enterococcal men- ingitis: Report of four cases and review. Clin Infect Dis 1994;18:233-239.
4. Brown DR, Reichman RC. Enterococcal meningitis: A sub- acute presentation. New York State J Med 1989; 89:92-93.
5. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin resistance enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Disease 2007;58:163-170.
6. Pintado V, Cabellos C, Moreno S, Meseguer MA, Ayats J, Viladrich PF. Enterococcal meningitis: a clinical study of 39 cases and review of the literature. Medicine (Baltimore) 2003; 82:346-364.
7. Moellering RC, JR. Enterococcus species, Streptococcus bo- vis and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. Fifth edition. New York. Churchill Livingstone 2005; 2411- 2421.
8. Elvy J, Porter D, Brown E. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faeca- lis with intraventricular daptomycin. J Antimicrob Chemother 2008;61:461-462.

9. Le J, Bookstaver PB, Rudisill CN, Hashem MG, Iqbal R, James CL, Sakoulas G. Treatment of Meningitis Caused by Vancomycin-Resistant Enterococcus faecium: High-Dose and Combination Daptomycin Therapy. Ann Pharmacother 2010;44:2001-2006.
10. Bain KT, Wittbrodt ET. Linezolid for the treatment of resistant gram-positive cocci. Ann Pharmacother 2001;35:566-575.